// App-Quantinova.ai

290 : Recurrence of Primary Biliary Cholangitis after Liver Transplantation Affects Graft Survival: A Multi‐Center Study from the Global PBC Study Group

Researchers

Presenter

  • Aldo J. Monta no-Loza

Principal Investigators

  • Davide Roccarina

  • Douglas Thorburn

  • Palak J. Trivedi

  • Gideon Hirschfield

  • Christophe Corpechot

  • Raoul Poupon

  • Jrme Dumortier

  • Alexie Bosch

  • Emiliano G. Giostra

  • Yvon Calmus

  • Albert Pares

  • Anna Reig

  • Irene Franceschet

  • Annarosa Floreani

  • Jorn C. Goet

  • Maren H. Harms

  • Henk R. van Buuren

  • Natalie Van den Ende

  • Frederik Nevens

  • Xavier Verhelst

  • Maria F. Donato

  • Federica Malinverno

Medical Centers

  • Gastroenterology and Liver Unit, Univeristy of Alberta, Edmonton, AB, Canada

  • Division of General Surgery, University Health Network, Toronto, Ontario, Canada

  • University of Toronto, Toronto, ON, Canada

  • Liver Failure Group, UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United Kingdom

  • Centre for Liver Research, University of Birmingham, Birmingham, UK

  • Reference Center for Inflammatory Biliary Diseases, Saint‐Antoine Hospital, Paris, France

  • Liver Transplant Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

  • Hepatology and Gastroenterology, University Hospitals of Geneva, Geneva, Switzerland

  • Liver Transplant Unit, Pitié‐Salpêtrière Hospital, Paris, France

  • BCLC Group, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain

  • Department of Surgery, Oncology and Gastroenterology -DiSCOG, University of Padova, Padova, Italy

  • Gastroenterology and Hepatology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, Netherlands

  • Liver and Biliopancreatic Disorders, UZ Leuven, Leuven, Belgium

  • Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium

  • Transplant Hepatology Unit, Gastroenterology and Hepatology, Maggiore Hospital Policlinico, Milan, Italy

Locations

  • Canada

  • United Kingdom

  • France

  • Switzerland

  • Spain

  • Italy

  • Netherlands

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Primary biliary cirrhosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved